Generic ciprofloxacin injection

FDA Consumer, Nov-Dec, 2006

The FDA has approved several Abbreviated New Drug Applications (ANDAs) for generic versions of Bayer Corp. Pharmaceutical Division's CIPRO I.V. Injection, a drug to treat certain bacterial infections. The approval, in August 2006, is an important step in the agency s effort to increase the availability of lower-cost generic medications.

Ciprofloxacin Injection USE is indicated for the treatment of infections, including urinary tract infections, lower-respiratory tract infections, bone and joint infections, complicated intra-abdominal infections, and skin and skin structure infections.

In 2005, CIPRO I.V. Injection was on the top 200 list of highest-selling brand-name drugs in the United States.

Ciprofloxacin Injection USE 10 mg/ mL (milligrams per milliliter), is packaged in 20 mL and 40 mL vials and a 120 mL pharmacy bulk package. The products are manufactured by multiple generic companies.